Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany (Orphanet Journal of Rare Diseases, (2022), 17, 1, (276), 10.1186/s13023-022-02420-8)

Hahn A, Günther R, Ludolph A, Schwartz O, Trollmann R, Weydt P, Weiler M, Neuland K, Schwaderer MS, Hagenacker T (2022)

Publication Type: Journal article, Erratum

Publication year: 2022

Journal

Orphanet Journal of Rare Diseases BioMed Central

Book Volume: 17

Article Number: 387

Journal Issue: 1

DOI: 10.1186/s13023-022-02548-7

Abstract

Following publication of the original article [1], we have been notified that there is a typographical error in the Fig. 1 text. It should be as per below: Figure 1: “111 patients received ≥ 1 risdiplam dose.

Authors with CRIS profile

Regina Trollmann Professur für Kinder- u. Jugendmedizin Schwerpunkt Neuropädiatrie

Involved external institutions

Justus-Liebig-Universität Gießen DE Germany (DE) Universitätsklinikum Carl Gustav Carus Dresden DE Germany (DE) Universität Ulm DE Germany (DE) Universitätsklinikum Münster DE Germany (DE) Universitätsklinikum Bonn DE Germany (DE) Universitätsklinikum Heidelberg DE Germany (DE) Roche Deutschland Holding GmbH DE Germany (DE) Universitätsklinikum Essen DE Germany (DE)

How to cite

APA:

Hahn, A., Günther, R., Ludolph, A., Schwartz, O., Trollmann, R., Weydt, P.,... Hagenacker, T. (2022). Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany (Orphanet Journal of Rare Diseases, (2022), 17, 1, (276), 10.1186/s13023-022-02420-8). Orphanet Journal of Rare Diseases, 17(1). https://doi.org/10.1186/s13023-022-02548-7

MLA:

Hahn, Andreas, et al. "Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany (Orphanet Journal of Rare Diseases, (2022), 17, 1, (276), 10.1186/s13023-022-02420-8)." Orphanet Journal of Rare Diseases 17.1 (2022).

BibTeX: Download